4
Changes in Ownership
Milestone Pharmaceuticals Inc. Filed Acc 0001415889-25-019771
Chief Commercial Officer acquired 66,666 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Muller Lorenz Chief Commercial Officer | 2025-07-11 | Grant or award | +66,666 | 175,052 | D | ||
| Derivatives | |||||||
| Muller Lorenz Chief Commercial Officer | 2025-07-11 | Grant or award · Series A Common Warrants (right to buy) | +66,666 | 66,666 | D | ||
| Muller Lorenz Chief Commercial Officer | 2025-07-11 | Grant or award · Series B Common Warrants (right to buy) | +66,666 | 66,666 | D | ||
Loading xslF345X05/form4-07152025_040705.xml…